CorMedix Inc.CorMedix Inc.CorMedix Inc.

CorMedix Inc.

No trades
See on Supercharts
Next report date
Report period
EPS estimate
Revenue estimate
Market capitalization
‪604.34 M‬USD
−0.80USD
‪−46.34 M‬USD
0.00USD
‪59.76 M‬
Beta (1Y)
2.07
Employees (FY)
82
Change (1Y)
+41 +100.00%
Revenue / Employee (1Y)
0.00USD
Net income / Employee (1Y)
‪−565.11 K‬USD

About CorMedix Inc.


CEO
Joseph Todisco
Headquarters
Berkeley Heights
Founded
2006
FIGI
BBG000Q4BQK0
CorMedix, Inc. is a pharmaceutical and medical device company, which engages in the development and commercialization of therapeutic products for the prevention and treatment of diseases and conditions. The company was founded by Antony E. Pfaffle on July 28, 2006 and is headquartered in Berkeley Heights, NJ.
Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:
‪0.00‬
Summarizing what the indicators are suggesting.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Displays a symbol's price movements over previous years to identify recurring trends.

Frequently Asked Questions


The current price of CRMD is 9.96 USD — it has decreased by −3.58% in the past 24 hours. Watch CorMedix Inc. stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on NASDAQ exchange CorMedix Inc. stocks are traded under the ticker CRMD.
CRMD stock has fallen by −8.03% compared to the previous week, the month change is a −17.00% fall, over the last year CorMedix Inc. has showed a 181.36% increase.
We've gathered analysts' opinions on CorMedix Inc. future price: according to them, CRMD price has a max estimate of 20.00 USD and a min estimate of 11.00 USD. Watch CRMD chart and read a more detailed CorMedix Inc. stock forecast: see what analysts think of CorMedix Inc. and suggest that you do with its stocks.
CRMD reached its all-time high on Apr 1, 2015 with the price of 52.00 USD, and its all-time low was 0.73 USD and was reached on Jun 15, 2012. View more price dynamics on CRMD chart.
See other stocks reaching their highest and lowest prices.
CRMD stock is 4.43% volatile and has beta coefficient of 2.07. Track CorMedix Inc. stock price on the chart and check out the list of the most volatile stocks — is CorMedix Inc. there?
Yes, you can track CorMedix Inc. financials in yearly and quarterly reports right on TradingView.
CorMedix Inc. is going to release the next earnings report on Apr 1, 2025. Keep track of upcoming events with our Earnings Calendar.
CRMD earnings for the last quarter are −0.05 USD per share, whereas the estimation was −0.12 USD resulting in a 59.02% surprise. The estimated earnings for the next quarter are 0.03 USD per share. See more details about CorMedix Inc. earnings.
CorMedix Inc. revenue for the last quarter amounts to ‪11.46 M‬ USD, despite the estimated figure of ‪10.35 M‬ USD. In the next quarter, revenue is expected to reach ‪19.59 M‬ USD.
CRMD net income for the last quarter is ‪−2.78 M‬ USD, while the quarter before that showed ‪−14.15 M‬ USD of net income which accounts for 80.38% change. Track more CorMedix Inc. financial stats to get the full picture.
No, CRMD doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
As of Nov 24, 2024, the company has 82.00 employees. See our rating of the largest employees — is CorMedix Inc. on this list?
Like other stocks, CRMD shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade CorMedix Inc. stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So CorMedix Inc. technincal analysis shows the sell today, and its 1 week rating is buy. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating CorMedix Inc. stock shows the buy signal. See more of CorMedix Inc. technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.